Iron metabolism in non-alcoholic fatty liver disease: A promising therapeutic target
Non-alcoholic fatty liver disease (NAFLD) has become the most common cause of chronic liver disease worldwide, and is closely associated with the increased risk of the prevalence of obesity and diabetes. NAFLD begins with the presence of >5% excessive lipid accumulation in the liver, and potentia...
Main Author: | Hanqing Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2022-12-01
|
Series: | Liver Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2542568422000459 |
Similar Items
-
Research progress on the role of ferroptosis in the pathogenesis of non-alcoholic fatty liver disease
by: XIAO Yanxin, LIU Yan, XU Lingling, ZHOU Yaru
Published: (2024-02-01) -
New Deferric Amine Compounds Efficiently Chelate Excess Iron to Treat Iron Overload Disorders and to Prevent Ferroptosis
by: Wenya Feng, et al.
Published: (2022-10-01) -
Deferasirox, an oral chelator in the treatment of iron overload
by: I. Portioli
Published: (2013-05-01) -
Iron Chelation as a Potential Therapeutic Approach in Acute Lung Injury
by: Xiyang Zhang, et al.
Published: (2023-07-01) -
The Impact of Sira Vedha (Phlebotomy) at the Right Elbow Joint in the Treatment of Non-Alcoholic Fatty Liver Disease - A Research Report
by: Gaurav Sawarkar, et al.
Published: (2024-12-01)